0
Abstract: Slide Presentations |

DIAGNOSTIC VALUE OF PROCALCITONIN AND C-REACTIVE PROTEIN IN DIFFERENTIATION OF PLEURAL EFFUSIONS FREE TO VIEW

Sang-Ha Kim, MD, PhD*; Shin-Tae Kim, MD; Chong-Whan Kim, MD; Bu-Ghil Lee, MD; Won-Yeon Lee, MD, PhD; Suk-Joong Yong, MD, PhD; Kye-Chul Shin, MD, PhD
Author and Funding Information

Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea


Chest


Chest. 2007;132(4_MeetingAbstracts):462. doi:10.1378/chest.132.4_MeetingAbstracts.462
Text Size: A A A
Published online

Abstract

PURPOSE: Malignancy is a common and important cause of exudative pleural effusions. Because pleural fluid cytology and pleural biopsy specimens do not provide a diagnosis in a high percentage of malignant effusions, several tumor markers have been studied. To overcome this limitation, we hypothesized that measurement of procalcitonin and C-reactive protein (CRP) would be useful in differentiating between trasudates and exudates and besides between benign and malignant effusion.

METHODS: We studied prospectively 178 consecutive patients with pleural effusion (malignant 57, tuberculous 51, parapneumonic 31, empyema 5, miscellaneous benign 7, transudative 27). We examined standard parameters of pleural effusion and measured serum and pleural procalcitonin using immunoluminometric assay. CRP in serum and pleural fluid was determined by turbidimetric immunoassay.

RESULTS: Pleural procalcitonin levels in exudate are significantly higher than those in transudate, 0.81±3.09 ng/mL and 0.12±0.12 ng/mL, respectively (p = 0.007). Pleural CRP levels are significantly elevated in exudate compared with transudate, 2.83±3.31 mg/dL and 0.74±0.67 mg/dL, respectively (p < 0.001). Pleural procalcitonin levels in benign effusion are significantly higher than those in malignant effusion, 1.15±3.82 ng/mL and 0.25±0.92 ng/mL, respectively (p = 0.032). Pleural CRP levels are significantly elevated in benign effusion compared with malignant effusion, 3.68±3.78 mg/dL and 1.42±1.54 mg/dL, respectively (p < 0.001). Pleural procalcitonin levels in non-tuberculous effusion are significantly higher than those in tuberculous effusion, 1.16±3.75 ng/mL and 0.13±0.37 ng/mL, respectively (p = 0.008).

CONCLUSION: Taken together, we conclude that the measurement of the level of procalcitonin and CRP in pleural fluid is helpful in differentiating between transudates and exudates. Moreover it is useful in differentiation between benign and malignant pleural effusions.

CLINICAL IMPLICATIONS: The measurement of the procalcitonin and CRP levels at the onset of pleural effusion may facilitate the differentiation of the cause of pleural effusions.

DISCLOSURE: Sang-Ha Kim, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, October 23, 2007

10:30 AM - 12:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543